Allergy Therapeutics Ltd. Expects Prelim Ragweed Vaccine Trial Results In Q1 2006

Allergy Therapeutics PLC said recruitment into the pivotal Ragweed allergy vaccine trial, R204, has been completed with 228 patients randomised into the study with preliminary results expected during the first quarter of 2006.